Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study

JL Reid, TC Wright Jr, MH Stoler… - American journal of …, 2015 - academic.oup.com
Objectives This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …
被引用次数：91 相关文章

Human papillomavirus oncogenic mRNA testing for cervical cancer screening: Baseline and longitudinal results from the CLEAR study

JL Reid, TC Wright, MH Stoler… - … journal of clinical …, 2015 - einstein.elsevierpure.com
Objectives: This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …

Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening.

JL Reid, TC Wright Jr, MH Stoler… - American Journal of …, 2015 - search.ebscohost.com
Objectives: This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …

Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study

JL Reid, TC Wright Jr, MH Stoler… - … journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …
[PDF] academia.edu

[PDF][PDF] Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening Baseline and Longitudinal Results From the CLEAR Study

JL Reid, TC Wright Jr, MH Stoler, J Cuzick - Am J Clin Pathol, 2015 - academia.edu
Objectives: This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …

Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.

JL Reid, TC Wright Jr, MH Stoler, J Cuzick… - American Journal of …, 2015 - europepmc.org
Objectives This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …
[PDF] jdwpathology.co.za

[PDF][PDF] HPV Oncogenic mRNA testing for Cervical Cancer Screening; Baseline and Longitudinal 2 Results from the CLEAR Study 3

JL Reid, TC Wright Jr, MH Stoler, J Cuzick… - jdwpathology.co.za
APTIMA® HPV Assay Performance in Women with ASC-US Pap Test Results Page 1 1 1 HPV
Oncogenic mRNA testing for Cervical Cancer Screening; Baseline and Longitudinal 2 Results …

Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.

JL Reid, TCJ Wright, MH Stoler, J Cuzick, PE Castle… - 2015 - cabidigitallibrary.org
Objectives: This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …
[PDF] jdwpathology.co.za

[PDF][PDF] Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening Baseline and Longitudinal Results From the CLEAR Study

JL Reid, TC Wright Jr, MH Stoler, J Cuzick - Am J Clin Pathol, 2015 - jdwpathology.co.za
Objectives: This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …
[PDF] archive.org

[PDF][PDF] Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening Baseline and Longitudinal Results From the CLEAR Study

JL Reid, TC Wright Jr, MH Stoler, J Cuzick - Am J Clin Pathol, 2015 - scholar.archive.org
Objectives: This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …